Allopregnanolone and depression and anxiety symptoms across the peripartum: an exploratory study

Arch Womens Ment Health. 2022 Apr;25(2):521-526. doi: 10.1007/s00737-021-01186-5. Epub 2021 Oct 29.

Abstract

Recent research has implicated allopregnanolone (ALLO), a neuroactive steroid and metabolite of progesterone, in perinatal mood and anxiety symptoms. We sought to add to the limited literature examining ALLO and mood and anxiety at multiple time points across the peripartum. We measured mood and anxiety symptoms and ALLO levels by ELISA at the second and third trimester (T2 and T3) and week 6 postpartum (W6) in N = 73 women with prior histories of mood and/or anxiety disorders and N = 38 healthy controls. Analytic methods included multivariate and logistic regressions with linear mixed effect models. Among all participants (N = 111), higher ALLO levels at W6 were associated with higher depression and anxiety scores: each one unit increase in log ALLO at W6 was associated with a 2.54 point increase on the Edinburgh Postnatal Depression Scale (EPDS) (95% CI: 0.73 to 4.33) and an 8.0 point increase on the Perinatal Anxiety Screening Scale (PASS) (95% CI: 3.82 to 12.6). In addition, the nature of the relationship between log ALLO level and psychological measures changed across time; from T2 to W6 for EPDS, β = 3.73 (95% CI:1.16, 6.30), p = 0.0045; for PASS β = 9.78 (95% CI:3.77, 15.79), p = 0.0014); from T3 to W6, for (EPDS, β = 2.52 (95% CI:0.08, 4.96), p = 0.043; for PASS β = 7.33 (95% CI:1.63, 13.02), p = 0.018). The relationship of log ALLO to mood and anxiety symptoms was the same among women with and without psychiatric histories. Our exploratory findings indicate that the relationship between ALLO and mood and anxiety symptoms may change across the peripartum.

Keywords: Allopregnanolone; Anxiety; Depression; Hormones; Postpartum; Pregnancy.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anxiety / diagnosis
  • Depression / diagnosis
  • Depression / metabolism
  • Depression, Postpartum* / diagnosis
  • Depression, Postpartum* / epidemiology
  • Female
  • Humans
  • Peripartum Period / psychology
  • Pregnancy
  • Pregnanolone*
  • Psychiatric Status Rating Scales

Substances

  • Pregnanolone